secwatch.observer — SEC 8-K summary
======================================

Issuer:     Covista Inc. (CVSA)
CIK:        0000730464
Form:       8-K
Filed at:   2023-10-26T23:59:59+00:00
Accession:  0001157523-23-001560
Event type: earnings
Sentiment:  positive
Materiality: 0.75
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Adtalem Q1 FY2024: revenue $368.8M, adjusted EPS $0.93; FY guidance raised
--------------------------------------------------------------------------

- GAAP net income $10.6M ($0.25 diluted EPS); adjusted EPS $0.93, up 3.3% YoY.
- Total enrollment 81,073 (+1.9% YoY); Chamberlain up 5.2%, Walden up 0.5%.
- FY2024 guidance raised: revenue $1,470-1,530M; adjusted EPS $4.25-4.45.
- Repurchased $92M of shares under $300M board authorization; net leverage 1.3x.
- Medical/Vet segment revenue down 3.8%, enrollment down 7.5% YoY.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/730464/000115752323001560/0001157523-23-001560-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/730464/000115752323001560/a53684541.htm
  HTML page:      https://secwatch.observer/filing/0001157523-23-001560

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer